Sparo Labs, a medical device startup founded by Washington University alums Abby Cohen and Andrew Brimer, was given U.S. Food and Drug Administration clearance for its Wing device.

The device measures lung function for people with asthma and other respiratory conditions. It plugs into a smartphone and can deliver immediate results on lung function before an asthma attack.

“It really is that very important and valuable piece and we wanted to make sure we could provide that data and that function in a way people feel confident using it. That’s where FDA clearance comes in. It’s really a testament to how our product works and its accuracy,” co-founder Cohen told EQSTL.

Cohen and Brimer founded the company in the Olin Business School’s Hatchery course at Washington University. The company has raised more than $2 million to date, and in 2015 the company pitched President Barack Obama at The White House’s first Demo Day.

Read more in the St. Louis Business Journal and EQSTL

Watch a video about Sparo Labs from Startup Connection: